Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Oct 17;19(1):229.
doi: 10.1186/s13075-017-1431-9.

Incretins in patients with rheumatoid arthritis

Beatriz Tejera-Segura  1 , Raquel López-Mejías  2 , María Jesús Domínguez-Luis  1 , Antonia M de Vera-González  3 , Alejandra González-Delgado  2 , Begoña Ubilla  2 , José M Olmos  4 , José L Hernández  4 , Miguel A González-Gay  5   6   7   8 , Iván Ferraz-Amaro  9
Affiliations

Incretins in patients with rheumatoid arthritis

Beatriz Tejera-Segura et al. Arthritis Res Ther. .

Abstract

Background: The precise mechanism linking systemic inflammation with insulin resistance (IR) in rheumatoid arthritis (RA) remains elusive. In the present study, we determined whether the incretin-insulin axis and incretin effect are disrupted in patients with RA and if they are related to the IR found in these patients.

Methods: We conducted a cross-sectional study that encompassed 361 subjects without diabetes, 151 patients with RA, and 210 sex-matched control subjects. Insulin, C-peptide, glucagon-like peptide-1 (GLP-1), gastric inhibitory polypeptide (GIP), dipeptidyl peptidase 4 (DPP-4) soluble form, and IR indexes by homeostatic model assessment (HOMA2) were assessed. A multivariable analysis adjusted for IR-related factors was performed. Additionally, ten patients and ten control subjects underwent a 566-kcal meal test so that we could further study the postprandial differences of these molecules between patients and control subjects.

Results: Insulin, C-peptide, and HOMA2-IR indexes were higher in patients than in control subjects. This was also the case for GLP-1 (0.49 ± 1.28 vs. 0.71 ± 0.22 ng/ml, p = 0.000) and GIP (0.37 ± 0.40 vs. 1.78 ± 0.51 ng/ml, p = 0.000). These differences remained significant after multivariable adjustment including glucocorticoid intake. Disease Activity Score in 28 joints with erythrocyte sedimentation rate (β coefficient 46, 95% CI 6-87, p = 0.026) and Clinical Disease Activity Index (β coefficient 7.74, 95% CI 1.29-14.20, p = 0.019) were associated with DPP-4 serum levels. GLP-1 positively correlated with β-cell function (HOMA2 of β-cell production calculated with C-peptide) in patients but not in control subjects (interaction p = 0.003). The meal test in patients with RA revealed a higher total and late response AUC for glucose response, a later maximal response of C-peptide, and a flatter curve in GIP response.

Conclusions: The incretin-insulin axis, both during fasting and postprandial, is impaired in patients with RA.

Keywords: Incretins; Insulin resistance; Rheumatoid arthritis.

PubMed Disclaimer

Conflict of interest statement

Ethics approval and consent to participate

The study protocol was approved by the institutional review committees at Hospital Universitario de Canarias and Hospital Universitario Marqués de Valdecilla (both in Spain), and all subjects provided written informed consent.

Consent for publication

Not applicable.

Competing interests

The authors declare that they have no competing interests.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Figures

Fig. 1
Fig. 1
Meal test curves of glucose, insulin, C-peptide, gastric inhibitory polypeptide, and glucagon-like peptide 1 concentrations in patients with rheumatoid arthritis and control subjects
See this image and copyright information in PMC

References

    1. Dupre J, Ross SA, Watson D, Brown JC. Stimulation of insulin secretion by gastric inhibitory polypeptide in man. J Clin Endocrinol Metab. 1973;37(5):826–828. doi: 10.1210/jcem-37-5-826. - DOI - PubMed
    1. Kreymann B, Williams G, Ghatei MA, Bloom SR. Glucagon-like peptide-1 7-36: a physiological incretin in man. Lancet. 1987;2(8571):1300–1304. doi: 10.1016/S0140-6736(87)91194-9. - DOI - PubMed
    1. Mentlein R, Gallwitz B, Schmidt WE. Dipeptidyl-peptidase IV hydrolyses gastric inhibitory polypeptide, glucagon-like peptide-1(7–36)amide, peptide histidine methionine and is responsible for their degradation in human serum. Eur J Biochem. 1993;214(3):829–835. doi: 10.1111/j.1432-1033.1993.tb17986.x. - DOI - PubMed
    1. Deacon CF, Johnsen AH, Holst JJ. Degradation of glucagon-like peptide-1 by human plasma in vitro yields an N-terminally truncated peptide that is a major endogenous metabolite in vivo. J Clin Endocrinol Metab. 1995;80(3):952–957. - PubMed
    1. Ferraz Amaro I, Díaz González F, González Juanatey C, González Gay MA. Insulin resistance and rheumatoid arthritis [in Spanish] Reumatol Clin. 2011;7(2):124–129. doi: 10.1016/j.reuma.2010.03.010. - DOI - PubMed